AVDL vs. HIVE

Last updated Jun 9, 2026

AVDL (Avadel Pharmaceuticals plc) and HIVE (HIVE Blockchain Technologies Ltd) are both stocks. AVDL operates in Drug Manufacturers - Specialty & Generic (Healthcare), while HIVE operates in Capital Markets (Financial Services). At a 0.12 correlation, their price movements are largely independent.

Performance

AVDL vs. HIVE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avadel Pharmaceuticals plc (AVDL) and HIVE Blockchain Technologies Ltd (HIVE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

AVDL

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

HIVE

• 1D: 5.04%
• 1M: 40.43%
• YTD: 53.49%
• 6M: 27.74%
• 1Y: 97.01%
• 3Y*: 9.70%
• 5Y*: -20.28%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AVDL vs. HIVE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
AVDL Avadel Pharmaceuticals plc	0.42%	105.04%	-25.57%	97.21%	-11.39%	20.96%	-11.52%	192.64%	-73.62%
HIVE HIVE Blockchain Technologies Ltd	53.49%	-9.47%	-37.09%	214.58%	-89.09%	39.68%	2,600.00%	-64.10%	-92.50%

Correlation

The correlation between AVDL and HIVE is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.21
Correlation (All Time) Calculated using the full available price history since Jan 12, 2018	0.12

The correlation between AVDL and HIVE shifts across timeframes, from -0.05 (1 year) to 0.21 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS AVDL : -$0.00 HIVE : -$0.33
PS Ratio AVDL : 8.72 HIVE : 3.39
Total Revenue (TTM) AVDL : $248.52M HIVE : $257.14M
Gross Profit (TTM) AVDL : $234.76M HIVE : $58.57M
EBITDA (TTM) AVDL : $10.13M HIVE : $87.81M

Return for Risk

AVDL vs. HIVE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIVE

HIVE Risk / Return Rank: 70
HIVE Sharpe Ratio Rank: 73
HIVE Sortino Ratio Rank: 76
HIVE Omega Ratio Rank: 72
HIVE Calmar Ratio Rank: 67
HIVE Martin Ratio Rank: 62

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVDL vs. HIVE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avadel Pharmaceuticals plc (AVDL) and HIVE Blockchain Technologies Ltd (HIVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	AVDL	HIVE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.03	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.22	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.12	—

Drawdowns

Drawdown Indicators

	AVDL	HIVE	Difference
Max Drawdown Largest peak-to-trough decline	—	-97.73%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-74.86%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-80.27%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-94.61%	—
Current Drawdown Current decline from peak	—	-85.24%	—
Average Drawdown Average peak-to-trough decline	—	-78.59%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	46.35%	—

Volatility

Volatility by Period

	AVDL	HIVE	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	39.11%	—
Volatility (6M) Calculated over the trailing 6-month period	—	66.45%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	95.15%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	93.06%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	109.22%	—

Dividends

AVDL vs. HIVE - Dividend Comparison

Neither AVDL nor HIVE has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both AVDL and HIVE in my portfolio?

AVDL and HIVE have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.